C4XD logo

C4X Discovery Holdings Share Price

Symbol: AIM:C4XDMarket Cap: UK£30.3mCategory: Pharmaceuticals & Biotech

C4XD Share Price Performance

C4XD Community Fair Values

    Recent C4XD News & Updates

    No updates

    C4X Discovery Holdings plc Key Details

    UK£24.7m

    Revenue

    UK£16.0k

    Cost of Revenue

    UK£24.7m

    Gross Profit

    UK£14.1m

    Other Expenses

    UK£10.6m

    Earnings

    Last Reported Earnings
    Jan 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    0.042
    Gross Margin
    99.94%
    Net Profit Margin
    42.81%
    Debt/Equity Ratio
    0%

    C4X Discovery Holdings plc Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About C4XD

    Founded
    2007
    Employees
    49
    CEO
    Clive Dix
    WebsiteView website
    www.c4xdiscovery.com

    C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.

    U.K. Market Performance

    • 7 Days: 1.6%
    • 3 Months: 7.6%
    • 1 Year: 7.9%
    • Year to Date: 8.1%
    The market has climbed 1.6% in the last 7 days, lead by the Materials sector with a gain of 5.8%. The market is up 7.9% over the last 12 months. Earnings are forecast to grow by 14% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading